期刊文献+

62例糖尿病肾病临床分析

Clinical analysis of 62 cases of diabetic nephropathies
下载PDF
导出
摘要 目的:探讨糖尿病肾病的早期诊断及发病因素。方法:对62例糖尿病肾病病人的临床资料进行回顾性分析。结果:62例中病情好转34例,无好转或病情加重17例,死亡11例。结论:糖尿病肾病发病与高血糖、高血压、脂质代谢异常、年龄等因素有关;检测尿蛋白方法简单快捷,对早期诊断及治疗有重要意义。 Objective: To explore the early diagnosis and Pathogenic Factorsof diabetic nephropathy.Methods: 62 cases of patients with diabetic nephropathy Clinical data were analyzed retrospectively which were treated.Results: 34 case got better,17 cases did not got better even got worse,11 cases died.Conclusion: The etiology of diabetic nephropathy is related to Hyperglycemia,Hypertension,Dyslipidemia,age etc,The method which detect urinary protein is ofgreat importance toearlydiagnosis and treatment ofdiabetic nephropathies.
出处 《安徽卫生职业技术学院学报》 2010年第3期15-15,共1页 Journal of Anhui Health Vocational & Technical College
关键词 肾病 糖尿病 2型 诊断 Nephrosis Diabetes Mellitus Type 2 Diagnosis
  • 相关文献

参考文献3

二级参考文献23

  • 1胡俊斌,魏文宁,丁桂芝,袁莉,刘仲萍.糖尿病患者凝血与纤溶状态初探[J].中华内分泌代谢杂志,1996,12(2):118-119. 被引量:32
  • 2Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach[J] . Am J Kidney Dis, 2000, 36:646 - 661.
  • 3American Diabetes Association. Treatment of hypertension in adults with diabetes[ J ]. Diabetes Care, 2003, 26 : S80 -S82.
  • 4Ravid M, Brosh D, Levi Z, et al. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminurie patients with type 2 diabetes mellitus. A randomized, controlled trial[J]. Ann Intern Med, 1998, 128:982-988.
  • 5Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria[J]. BMJ, 1991,302:210 - 216.
  • 6Marre M, Chatellier G, LeBlanc Ⅱ, et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria[J]. Br Med J , 1998, 297:1092 - 1095.
  • 7Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitas: results of the HOPE study and MICRO-HOPE substudy[J]. Lancet, 2000, 355:253- 259.
  • 8Parring HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes[J]. N Engl J Med, 2001, 345:870 - 878.
  • 9Lewis E J, Hunsicker LG, Bain RP, et al. The effect of angiotesin-converting enzyme inhibition on diabetic nephropathy[J].N Engl J Med, 1993, 329:1456 - 1462.
  • 10Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J]. N Engl J Med,2001, 345:851 - 860.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部